Skip to Main Content

Paper Details

Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355.
J Natl Cancer Inst
1
2024
Author NameAffiliation
David W CesconPrincess Margaret Cancer Centre, University Health Network, University of Toronto
  • 1 - 1

Datasets

Release 1.2